A historic issue of the Annals: Three papers examine paracetamol in osteoarthritis

Annals of the Rheumatic Diseases

Volumn 63, Issue 8, 2004, Pages 897-900

  Neame, R ^b   Zhang, W ^a   Doherty, M ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b KING S MILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIRHEUMATIC AGENT; CELECOXIB; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; IBUPROFEN; MISOPROSTOL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; TRAMADOL;

ANALGESIA; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; HEALTH CARE DELIVERY; HUMAN; JOINT STIFFNESS; KNEE OSTEOARTHRITIS; KNEE PAIN; META ANALYSIS; OSTEOARTHRITIS; PAIN ASSESSMENT; PATIENT SELECTION; PHYSICAL ACTIVITY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; VISUAL ANALOG SCALE;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; HUMANS; OSTEOARTHRITIS; RANDOMIZED CONTROLLED TRIALS;

EID: 3242699562     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.020727     Document Type: Review

References (21)

1. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Repart of a Task Force of the standing Committee for International Clinical Studies Including Therapeutic Trials. Ann Rheum Dis 2003;62:1145-55.
2. ACR. American College of Rheumatology Subcommittee on osteoarthritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update, Arthritis Rheum 2000;43:1905-15.
3. Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE. The importance of placebo effects in pain treatment and research. JAMA 1994;20:1609-14.
4. Amadio P, Cummings DM. Evaluation of acetaminophen in the management of osteoarthritis of the knee. Curr Ther Res 1983;34:59-66.
5. Zoppi M, Peretti G, Boccard E. Placebo-controlled study of the analgesic efficacy of an effervescent formulation of 500 mg paracetamol in arthritis of the knee or hip. Eur J Pain 1995;16:42-8.
6. Case JP. Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis. Arch Intern Med 2003;163:169-78.
7. Pincus T, Fort JF, Mangal B, Koch G, Wolfe F, Moskowitz R, et al. Patient Preference for Placebo, Acetaminophen (paracetamol), or Celebrex Effectiveness Study (PACES-1): a double-blinded, randomised, cross-over clinical trial in patients with osteoarthritis of the hip or knee [abstract]. Ann Rheum Dis 2003;62(suppl 1):73.
8. Zhang W, Jones A, Doherty M. Does paracetamol (acetaminophen) reduce the pain of osteoartrtritis? - a meta-analysis of randomised controlled trials. Ann Rheum Dis 2004;63:901-7, doi: 10.1136/ard.2003.018531 [Published Online First: 5 March 2004].
9. Miceli-Richard C, Le Bars M, Schmidely N, Dougados M. Paracetamol in osteoarthritis of the knee. Ann Rheum Dis 2004;63:923-30.
10. Jordan KM, Sawer S, Coakley P, Smith HE, Cooper C, Arden NK. The use of conventional and complementary treatments for knee osteoarthritis in the community. Rheumatology (Oxford) 2004;43:381-4.
11. Whitney CW, Von Korff M. Regression to the mean in treated versus untreated chronic pain. Pain 1992;50:281-5.
12. Pincus T, Koch G, Lei H, Mangol B, Sokka T, Moskowitz R, et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Ann Rheum Dis 2004;63:931-9.
13. Cohen J. Statistical power analysis for the behavioral sciences, 2nd ed. Hillsdale, NJ: Lawrence Erlboum Associates, 1988.
14. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminopnen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991;325:87-91.
15. Williams HJ, Ward JR, Egger MJ, Neuner R, Brooks RH, Clegg DO, et al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993;36:1196-206.
16. Pincus T, Koch GG, Sokka T. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum 2001;44:1587-98.
17. Geba GP, Weaver AL, Polis AB, Dixon ME, Scnitzer TJ. Vioxx ACT (VACT) Group. Vioxx ACT (VACT) Group. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomised trial. JAMA 2002;287:64-71.
18. Doherty M, Dougados M. Evidence-based management of osteoarthritis: practical issues relating to the data. Best Pract Res Clin Rheumatol 2001;15:517-25.
19. Altman D, Schulz KF, Moher D, Egger M, Dovidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: elaboration and explanation. Ann Intern Med 2001;134:663-94.
20. Dougados M, LeClaire P, Van der Heijde D, Bloch DA, Bellamy N, Altaian RD. Response criteria for clinical trials on osteoarthritis of the knee and hip. Osteoarthritis Cartilage 2000;8:395-403.
21. Carr A. Problems in measuring or interpreting change in patient outcomes. Osteoarthritis Cartilage 2002;10:503-5.